OVERVIEW OF THE PHARMACEUTICAL MARKET IN THE USA

OVERVIEW

Despite assertions from some stakeholders, the r e-election of Barack Obama as President of the United States is not bad news for pharmaceutical companies and medical device manufacturers, primarily because we expect continuation of existing policies that have generally been favourable. However, we caution that further reforms to the he althcare sector are inevitable, due to unsustainable spending on medical services, by both the public and private sectors.

Headline Expenditure Projections

Pharmaceuticals: US$337.1bn in 2011 to US$343.1bn in 2012; +1.3% growth in local currency terms. Forecastslightly down from Q4 12.
Healthcare: US$2,708bn in 2011 to US$2,844bn in 2012; +5.0% growth in local currency terms. Forecastslightly down from Q4 12.
Medical devices: US$133bn in 2011 to US$138bn in 2012; +4.6% growth in local currency terms. Forecastslightly down from Q4 12.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/212654

Table of Contents

BMI Industry View7
SWOT9
Political11
Economic12
Business Environment13
Industry Forecast14
Pharmaceutical Market Forecast14

Table: Pharmaceutical Sales, Historical Data And Forecasts (United States 2010-2018)16

Healthcare Market Forecast16

Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2010-2018)19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2010-2018)20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2010-2018)20

Prescription Drug Market Forecast20

Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United States 2010-2018)22
Table: Number Of Dispensed Prescriptions By Therapy Area In The US (mn)22
Table: Number Of Dispensed Prescriptions By Active Ingredient In The US (mn)23

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.